It acts via a heterodimeric receptor composed of IL-31Rα and oncostatin M receptor β and expression of IL-31 correlates with the expression of IL-4 and IL-13 suggesting that IL-31 is involved in Th2-mediated skin inflammation [15–17]. This evidence concerns the gene IL31RA and dermatitis.